Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories
—Sabizabulin for COVID-19 Emergency Use Authorization Application Submitted to U.S. FDA in June 2022– –The…